Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
LHSS conducted an assessment of the accuracy of drug scheduling tracking systems and developed recommendations to strengthen antiretroviral stockout and distribution monitoring.
This Catalog allows practitioners to consider which interventions have more robust evidence bases to support their practical application, such as: enhancing worker and supervisor competencies through training, offering nonfinancial incentives for high performers, practicing task sharing to promote cost savings, implementing digital solutions to expand access to services, and reducing costs of procuring and distributing pharmaceutical products.
This primer is designed to help supply chain practitioners in governments, the private sector, donor agencies, and implementing partners understand the value of political economy analysis (PEA) and how it can help improve outcomes when implementing supply chain interventions and reforms.
New efforts will make health care more affordable for residents in 10 municipalities.
Join us to learn how thinking and working politically and using political economy analysis or PEA can strengthen efforts to reform health commodity supply chains.
This document describes the process to be followed for the regular revisions of the EHSP and presents important elements that support the updating, so that an EHSP that is a sustainable, equitable, and accessible—within financial and other constraints—is delivered to the population.
LHSS is supporting local government institutions in Bangladesh’s densely populated Rajshahi and Sylhet Divisions to expand access to primary health services and reduce out-of-pocket expenditures for low-income urban residents.
LHSS conducted an assessment of Uzbekistan supply chain management system for COVID-19 and emergency commodities.
This brief highlights learnings from working with local government leaders of two city corporations and ten district-level municipalities from the Rajshahi and Sylhet divisions in Bangladesh.
In Bangladesh, LHSS has built relationships with ministries, departments, and development partners to support its objective of assisting urban primary health care delivery. This newsletter provides detailed information about the latest news, updates, and activities in Bangladesh.
LHSS tiene como objetivo fortalecer la capacidad del Ministerio de Salud para garantizar la disponibilidad de productos para el VIH (ARV y dispositivos médicos) para la población migrante venezolana en Perú. Como parte de este esfuerzo, LHSS estimó la demanda de productos relacionados con el VIH relacionados con esta población, incluidos detalles como el tipo, la cantidad y el momento.
This report provides a summary of the results of the quantification of demand for HIV commodities for the Venezuelan migrant population in Peru. It includes the capabilities and limitations of the quantification model, its approach to quantification, and the sources used.
This fact sheet provides a summary of activity progress in Central Asia as well as results and impact.
Qaqish B, Sallam M, Al-Khateeb M, Reisdorf E, Mahafzah A. Assessment of COVID-19 Molecular Testing Capacity in Jordan: A Cross-Sectional Study at the Country Level. Diagnostics. 2022; 12(4):909. https://doi.org/10.3390/diagnostics12040909
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.